One hundred and twenty-one isolates of endophytic fungi were recovered from leaves of the bioactive Brazilian plant species Ageratum myriadenia, Palicourea tetraphylla, Piptadenia adiantoides, and Trixis vauthieri. All fungal isolates were cultivated in liquid media and crude extracts were obtained with ethyl acetate. The crude extracts were tested in bioassay panels using Leishmania amazonensis, Trypanosoma cruzi, the enzyme trypanothione reductase (TryR) from Trypanosoma cruzi, and three human cancer cell lines. Thirty-three extracts (27.2%) exhibited at least one biological activity. Seventeen extracts (14%) were cytotoxic against one or more human cancer cell line with the IC 50 values ranged of >0.2 to 25 µg/mL. Twenty-four extracts (19.8%) inhibited the activity of TryR, and three showed ability to inhibit the growth of T. cruzi above 60% and their IC 50 values ranged among 1 to 10 µg/mL. Eleven extracts (9%) were able to inhibit the growth of L. amazonensis and showed with IC 50 values ranged among 4.6 to 24.4 µg/mL. The endophytic fungi were identified as belonging to the genera Alternaria, Arthrinium, Cochliobolus, Colletotrichum, Penicillium, Fusarium, and Gibberella. An interesting result was obtained for the bioactive isolates UFMGCB 508, 537, 899 and 903, which were related to fungi associated with medicinal plants native to Asia, Australia, Africa, and Polynesia. These results indicate that bioactive plants living in Brazilian ecosystems are a potential host of endophytic fungi able to produce bioactive prototype molecules for drug development against neglected tropical diseases.
INTRODUCTION
Endophytic fungi are found in almost all plants, including trees, grasses, and herbaceous plants. Most endophytic fungi belong to the Ascomycota and their anamorphic stages, which live asymptomatically in plant tissues (12) . These fungi have also been recognised as a repository of novel secondary metabolites of pharmaceutical importance. Fifty-one percent of the biologically active substances obtained from these microorganisms were previously unknown (26, 29) , and the broad diversity and taxonomic spectrum exhibited by these fungi make them especially interesting for secondary metabolite screening programs.
According to Strobel (29) , reasonable hypotheses should govern the plant selection strategy for the discovery of bioactive endophytic fungi; one of these includes plants that exhibit medicinal or pharmacological activities. Recent studies have demonstrated that endophytic fungi living in medicinal plants exert a wide range of biological activities (12, 20) .
However, there is little information on the fungal endophyte communities associated with bioactive plants living in Brazilian ecosystems. In this study four plants known for their biological activities were selected to endophytic fungi recovered. Palicourea tetraphylla has been used in traditional Brazilian medicine to treat tumours of joints and limbs, and indurations of the prostate (11) ; Piptadenia adiantoides, popularly known as "Calombi-branco" is used as food and for handcrafting (4) ; Ageratum myriadenia produce metabolites with cytotoxic and trypanocidal activities (27) ; and Trixis vauthieri has the ability to produce trixol, a trypanocidal compound active against the protozoan tropical parasite T.
cruzi (22) .
In previous studies, we showed that the fungi isolated from Brazilian ecosystems are able to produce bioactive secondary metabolites against pathogenic microorganisms (23, 24) , Trypanosoma cruzi, and human tumour cells (5, 25) . In connection with our program to discover bioactive fungal metabolites, this study focuses on the ability of endophytic fungi recovered from the pharmacological plants A. myriadenia, P. tetraphylla, P. adiantoides, and T. vauthieri to produce secondary metabolites with cytotoxic, leishmanicidal, and trypanocidal activities.
MATERIAL AND METHODS

Sample collection
Plants were collected in the Private Natural Heritage
Reserve of the Sanctuary of the Caraça (20º05'S and 43º27'W), which is situated in the Espinhaço Mountain region and includes the biomes Brazilian Savanna ("Cerrado") and high- 
Preparation of fungal extracts
The fermentation and crude extract fungi productions for Endophytic fungi associated with bioactive plants secondary metabolites recovered were previous established by by Rosa et al. (24) . Briefly, Pre-inocula for the cultures were prepared by aseptically transferring three 5 mm discs from each microorganism on MEA (2% malt extract, 0.1% peptone,
1.5% glucose, and 1.5% agar) slants into unbaffled 250 mL Clomipramine, a known TryR inhibitor (3), was used at 16 µg/mL as a control drug. It has been used as the reference compound against which to compare the potency of newly tested substances. The experiments were repeated twice.
Assay with Leishmania amazonensis
In vitro assay with amastigote intracellular forms of
Trypanosoma cruzi
In vitro assay with amastigote forms of T. cruzi was 
Assay with human cancer cell lines
The effect of crude extract on the survival and growth of the human cancer cell lines UACC-62 (melanoma), MCF-7
(breast), and TK-10 (renal) was determined using a colorimetric method developed at the National Cancer
Institute-USA (17) . Briefly, cells were inoculated in 96-well plates and allowed to stabilize for 24 h in a CO 2 incubator at 37°C. Solutions of extracts were added to attain the desired concentrations, and plates were incubated for 48 h under the same conditions. Trichloroacetic acid was added to each well to precipitate the proteins, which were quantified in a colorimetric assay using the dye sulphorodamine B. All assays were run in triplicate wells and repeated at least once.
Etoposide at 16 µg/mL and cancer cell lines without fungal extracts were used in parallel as positive and negative controls, respectively. Results are expressed as percentage of growth inhibition in comparison to the control without drug.
Statistical analysis
The software GraphPad Prism version 4.03 was used to calculate the IC 50 values using the non-linear curve fitting of two or more independent experimental datasets to a four parameter logistic dose-response model. No constraints were applied to the curve fitting calculations. Likelihood model was used to estimate evolutionary distance.
DNA extraction, amplification and sequencing
RESULTS AND DISCUSSION
In this study, crude extracts of 121 fungal endophytes were obtained from four pharmacological plants present in
Brazilian ecosystems, which were tested in different biological assay models. Eight bioactive isolates were recovered from A. against TryR suggest the presence of trypanocidal compounds in the extracts of these fungi. The extracts that showed actives 90% in TryR assays were tested against T. cruzi (Table 2) .
Among these, three extracts produced by endophytic isolates UFMGCB 508, 533, and 536 showed abilities to inhibit more or equal 60% the growth of T. cruzi. The IC 50 of these extracts were determinate and ranged of 1 to 10 µg/mL ( were similar to uncultured fungi. An interesting result was obtained for the isolates UFMGCB 508 and UFMGCB 537, which exhibited 97% and 98% identity, respectively, with an
Uncultured fungus (GenBank accession number AJ877196) that was recovered from leaves of the Heterosmilax japonica Kunth, known pharmaceutical plant used in Chinese traditional medicine (9) . The phylogenetic analysis of the isolates UFMGCB 508 and 537 showed only seven (1.4%) and one (0.2%) nucleotide differences in the ITS region, respectively, when compared to the Uncultured fungus (GenBank accession number AJ877196) from the H. Japonica (Figure 1 ). The isolate UFMGCB 568 present showed 98% sequence identity and five (1%) nucleotide differences in the ITS region to an Uncultured endophytic fungus (GenBank accession number EF505005) recovered from Zea mays (maize) (19) .
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